FRM
Fox Run Management’s Amicus Therapeutics FOLD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-21,449
| Closed | -$175K | – | 986 |
|
|
2025
Q1 | $175K | Sell |
21,449
-41,121
| -66% | -$336K | 0.03% | 816 |
|
|
2024
Q4 | $589K | Buy |
62,570
+30,162
| +93% | +$284K | 0.11% | 381 |
|
|
2024
Q3 | $346K | Buy |
+32,408
| New | +$346K | 0.08% | 493 |
|
|
2023
Q1 | – | Sell |
-12,262
| Closed | -$150K | – | 751 |
|
|
2022
Q4 | $150K | Sell |
12,262
-373
| -3% | -$4.55K | 0.06% | 524 |
|
|
2022
Q3 | $132K | Buy |
+12,635
| New | +$132K | 0.05% | 528 |
|
|
2021
Q4 | – | Sell |
-27,620
| Closed | -$264K | – | 553 |
|
|
2021
Q3 | $264K | Buy |
+27,620
| New | +$264K | 0.17% | 276 |
|
|
2019
Q3 | – | Sell |
-16,343
| Closed | -$204K | – | 436 |
|
|
2019
Q2 | $204K | Buy |
+16,343
| New | +$204K | 0.14% | 367 |
|
|
2018
Q4 | – | Sell |
-12,156
| Closed | -$147K | – | 585 |
|
|
2018
Q3 | $147K | Sell |
12,156
-8,225
| -40% | -$99.5K | 0.06% | 503 |
|
|
2018
Q2 | $318K | Buy |
+20,381
| New | +$318K | 0.1% | 408 |
|